Skip to content

A multicenter randomized, double-blind, placebo-controlled trial for Yi-Tong Cheng-Zhang probiotic solid drink for removal out of lead in children

A multicenter randomized, double-blind, placebo-controlled trial for Yi-Tong Cheng-Zhang probiotic solid drink for removal out of lead in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023684
Enrollment
Unknown
Registered
2019-06-07
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlead in children

Interventions

The experimental group:YiTongChengZhang probiotics solid drink,one bag per day
The control group:YiTongChengZhang probiotics solid drink placebo,one bag per day

Sponsors

Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medical
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. Children aged 1-6 (including 1 and 6 years old); 2. The level of lead in venous blood was 50-199 ug/L 3. Other aspects of health of the subjects; 4. Subjects, their parents or legal guardians are able and willing to to comply with research guidance; 5. According to the judgement of the investigator/physician/researcher, the subjects are suitable to participate in this study; 6. Subject's parents or legal guardians sign written informed consent.

Exclusion criteria

Exclusion criteria: 1. The subjects'parents or legal guardians could not master any local language; 2. Those diagnosed with lead poisoning; 3. A past history of diagnosis of chronic or major illness; 4. Respiratory and/or intestinal infections and other digestive tract diseases occurred in the past two weeks. 5. Take probiotic products in the last two weeks; 6. Take any medicine in the last two weeks; 7. Failure to follow the research protocol (or the investigator is not sure if the parent is willing or able to comply with the protocol); 8. Subjects are participating in or will participate in another clinical or food study.

Design outcomes

Primary

MeasureTime frame
blood lead;

Secondary

MeasureTime frame
gastrointestinal symptoms;growth indicators;

Countries

China

Contacts

Public ContactHong Li

Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medical

lihongscmc@aliyun.com+86 18930830869

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026